From a Seasoned pharmacologist
messages.yahoo.com
>>about the affect of the PPA announcement on retail cough and cold---the results will be huge.
1. MD's will be warning patients about OTCs containing PPA.
2. Pharmacists will do likewise when consulted.
3. The knowledgable shopper will be label-reading to avoid PPA.
IMO this report has presented GUMM with a battleship to use to attack the entrenched cough and cold products (most of which contain PPA). Just imagine the advertising streamers.
CONTAINS NO PPA
CAUSES NO DROWSINESS
HAS NO SIDE AFFECTS
and, best of all
IT WORKS-REDUCES COLDS TO HOURS, NOT DAYS
I would be surprised if this report didn't hang around well into the cold season, as updates become available. The press loves to scare the pants off of its readers, and the public devours all of it.
Sorry, but I'm not sure I understand your question about "clinical pharmacology". Those who have PPA products will try to produce pharmacology to dispute the report, you can bet on that. (As I type this they just repeated the PPA news flash on CNBC) And the FDA will expedite research to prove/disprove so they can take action if needed. (Since FDA is certainly politically influenced, and there are big dollar companies with PPA products, I would be amazed if they acted quickly, without further study.) And, in truth, they should have to justify the study being quoted---after all PPA has been around for a long time, and medicine has embraced it.
But, face it, a continuing controversy keeps the question in the publics eye---which is just what we would like. So a ban, or continuing controversy, either way GUMM wins. I love it. << |
